Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

73
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival of Squamous Cell Carcinoma Versus Adenocarcinoma in Resected Stage I-III Non-small Cell Lung Cancer.

Annals of surgical oncology·2026
Same author

Case 347: Tracheobronchial Smooth Muscle Atrophy and Separation.

Radiology·2026
Same author

Impact of Social Support on Patient-Reported Outcomes in Cardiothoracic Surgery: A Systematic Review.

The Journal of surgical research·2026
Same author

Social Vulnerability Index is Associated with Increased Risk of Malignancy in Screen-Detected High-Risk Pulmonary Nodules.

Lung·2026
Same author

A Systematic Review Showing the Comparative Efficacy and Safety of Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection in the Management of Colorectal Neoplasia.

Cureus·2026
Same author

Multi-colour and red emissions from a small donor-acceptor molecule by breaching Kasha's rule.

Chemical communications (Cambridge, England)·2026

Related Experiment Video

Updated: May 13, 2025

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

1.7K

Exploratory Algorithms to Aid in Risk of Malignancy Prediction for Indeterminate Pulmonary Nodules.

Laurel Jackson1, Claire Auger2, Nicolette Jeanblanc1

  • 1Abbott Diagnostics Division, Abbott Laboratories, Chicago, IL 60064, USA.

Cancers
|April 14, 2025
PubMed
Summary

This study developed a model using biomarkers and patient data to predict the malignancy risk of indeterminate pulmonary nodules (IPNs) found during lung cancer screening. The new model shows improved accuracy over existing methods, potentially reducing unnecessary follow-ups.

Keywords:
algorithmcirculating biomarkersindeterminate pulmonary noduleslow-dose CT radiographylung cancer screeningrisk stratification

More Related Videos

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.3K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

259

Related Experiment Videos

Last Updated: May 13, 2025

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

1.7K
Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.3K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

259

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Radiology

Background:

  • Lung cancer screening reduces mortality but faces challenges in managing indeterminate pulmonary nodules (IPNs).
  • Accurate risk stratification of IPNs is crucial to avoid unnecessary invasive procedures and diagnostic delays.
  • Current methods for IPN risk assessment have limitations in predicting malignancy.

Purpose of the Study:

  • To develop and validate a predictive model for IPN malignancy risk.
  • To integrate demographic, clinical, radiographic, and circulating biomarker data for improved prediction.
  • To compare the performance of the novel model against the established Mayo Score.

Main Methods:

  • A case-control study included 379 patients with IPNs (251 lung tumors, 128 non-malignant).
  • Data comprised demographic, clinical (smoking history), radiographic (nodule characteristics), and plasma biomarker levels.
  • A multivariable model was built using 70% training data and validated on 30% testing data.

Main Results:

  • A predictive model incorporating age, lesion size, pack-years, extrathoracic cancer history, upper lobe location, spiculation, hs-CRP, NSE, Ferritin, and CA-125 was developed.
  • This model achieved superior performance (AUC = 0.872 training, 0.842 testing) compared to the Mayo Score (AUC = 0.816 training, 0.787 testing).
  • The novel algorithm demonstrated enhanced accuracy in predicting malignancy risk for IPNs.

Conclusions:

  • A simplified algorithm combining biomarkers, clinical, and demographic data shows promise for predicting malignancy in screen-detected IPNs.
  • This approach may reduce the need for serial imaging and mitigate risks associated with diagnostic delays.
  • Further validation is recommended to confirm the clinical utility of this predictive model.